移民健康与早发结直肠癌差异:西班牙早发结直肠癌联合会的研究结果。

IF 3.2 Q2 ONCOLOGY JCO Global Oncology Pub Date : 2024-11-01 Epub Date: 2024-11-21 DOI:10.1200/GO-24-00393
José Perea, Marc Martí-Gallostra, Ariadna García-Rodríguez, Rosario Vidal-Tocino, José A Alcázar, Irene López-Rojo, Sara Encinas García, Elena Hurtado, Luis M Jiménez, Edurne Álvaro, Ana Burdaspal, Gonzalo Sanz, Rodrigo Sanz López, Marta Jiménez Toscano, Mar Iglesias Comas, Fernando Jiménez, Adriana Cavero, Francesc Balaguer, María Daca, Araceli Ballestero, Javier Die Trill, Sirio Melone, José A Rueda, Sergio Hernández-Villafranca, Damián García-Olmo, Carlos Pastor, Alicia Alvarellos, Lorena Brandáriz, Cristina Viyuela, Alfredo Vivas, Paula Muñoz, Rogelio González-Sarmiento, Andreana N Holowatyj
{"title":"移民健康与早发结直肠癌差异:西班牙早发结直肠癌联合会的研究结果。","authors":"José Perea, Marc Martí-Gallostra, Ariadna García-Rodríguez, Rosario Vidal-Tocino, José A Alcázar, Irene López-Rojo, Sara Encinas García, Elena Hurtado, Luis M Jiménez, Edurne Álvaro, Ana Burdaspal, Gonzalo Sanz, Rodrigo Sanz López, Marta Jiménez Toscano, Mar Iglesias Comas, Fernando Jiménez, Adriana Cavero, Francesc Balaguer, María Daca, Araceli Ballestero, Javier Die Trill, Sirio Melone, José A Rueda, Sergio Hernández-Villafranca, Damián García-Olmo, Carlos Pastor, Alicia Alvarellos, Lorena Brandáriz, Cristina Viyuela, Alfredo Vivas, Paula Muñoz, Rogelio González-Sarmiento, Andreana N Holowatyj","doi":"10.1200/GO-24-00393","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>To better understand immigration disparities among a Spanish Early-Onset Colorectal Cancer (SECOC) subset, according to the country of origin.</p><p><strong>Patients and methods: </strong>We selected 250 consecutive participants from the SECOC consortium. Data on baseline patient and tumor characteristics, family history of colorectal cancer (CRC), and follow-up were collected. The presence of mismatch repair deficiency was also assessed. Special data regarding country of origin, time of stay in Spain in case of other different country, and a 10-year cutoff that specifies the obtaining of Spanish nationality defined the variables of interest for comparison.</p><p><strong>Results: </strong>Seventy-five percent of patients with early-onset CRC (EOCRC) (188) were born in Spain, whereas the other 25% were born outside of Spain. The mean time of living in Spain until the EOCRC diagnosis was 16.5 years. Comparatively, most of the analyzed features showed equivalent proportions between cohorts. Only Spanish patients appeared to have more familial cancer component in first degree in general (32.3%; <i>P</i> = .01), compared with non-Spaniards, which showed a predominant sporadic component (56.4%; <i>P</i> < .001). Among immigrants, those patients living in Spain before CRC diagnosis ≤10 years were younger at diagnosis (39.1 <i>v</i> 42.5), more frequently male (77.8 <i>v</i> 47.7), were in more advanced stages (88.8% diagnosed at stage III and IV [<i>P</i> = .01]), and had a worse prognosis regarding recurrence rates (29.4% <i>v</i> 6.3%).</p><p><strong>Conclusion: </strong>Although there were few differences between Spanish and non-Spanish EOCRC, the most remarkable difference was that linked with the situation of those immigrants who have recently arrived in Spain, in relation to their lower health coverage, which could be associated with the delay in the diagnosis and their subsequent worse prognosis.</p>","PeriodicalId":14806,"journal":{"name":"JCO Global Oncology","volume":"10 ","pages":"e2400393"},"PeriodicalIF":3.2000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Immigrant Health and Early-Onset Colorectal Cancer Disparities: Results From the Spanish Early-Onset Colorectal Cancer Consortium.\",\"authors\":\"José Perea, Marc Martí-Gallostra, Ariadna García-Rodríguez, Rosario Vidal-Tocino, José A Alcázar, Irene López-Rojo, Sara Encinas García, Elena Hurtado, Luis M Jiménez, Edurne Álvaro, Ana Burdaspal, Gonzalo Sanz, Rodrigo Sanz López, Marta Jiménez Toscano, Mar Iglesias Comas, Fernando Jiménez, Adriana Cavero, Francesc Balaguer, María Daca, Araceli Ballestero, Javier Die Trill, Sirio Melone, José A Rueda, Sergio Hernández-Villafranca, Damián García-Olmo, Carlos Pastor, Alicia Alvarellos, Lorena Brandáriz, Cristina Viyuela, Alfredo Vivas, Paula Muñoz, Rogelio González-Sarmiento, Andreana N Holowatyj\",\"doi\":\"10.1200/GO-24-00393\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>To better understand immigration disparities among a Spanish Early-Onset Colorectal Cancer (SECOC) subset, according to the country of origin.</p><p><strong>Patients and methods: </strong>We selected 250 consecutive participants from the SECOC consortium. Data on baseline patient and tumor characteristics, family history of colorectal cancer (CRC), and follow-up were collected. The presence of mismatch repair deficiency was also assessed. Special data regarding country of origin, time of stay in Spain in case of other different country, and a 10-year cutoff that specifies the obtaining of Spanish nationality defined the variables of interest for comparison.</p><p><strong>Results: </strong>Seventy-five percent of patients with early-onset CRC (EOCRC) (188) were born in Spain, whereas the other 25% were born outside of Spain. The mean time of living in Spain until the EOCRC diagnosis was 16.5 years. Comparatively, most of the analyzed features showed equivalent proportions between cohorts. Only Spanish patients appeared to have more familial cancer component in first degree in general (32.3%; <i>P</i> = .01), compared with non-Spaniards, which showed a predominant sporadic component (56.4%; <i>P</i> < .001). Among immigrants, those patients living in Spain before CRC diagnosis ≤10 years were younger at diagnosis (39.1 <i>v</i> 42.5), more frequently male (77.8 <i>v</i> 47.7), were in more advanced stages (88.8% diagnosed at stage III and IV [<i>P</i> = .01]), and had a worse prognosis regarding recurrence rates (29.4% <i>v</i> 6.3%).</p><p><strong>Conclusion: </strong>Although there were few differences between Spanish and non-Spanish EOCRC, the most remarkable difference was that linked with the situation of those immigrants who have recently arrived in Spain, in relation to their lower health coverage, which could be associated with the delay in the diagnosis and their subsequent worse prognosis.</p>\",\"PeriodicalId\":14806,\"journal\":{\"name\":\"JCO Global Oncology\",\"volume\":\"10 \",\"pages\":\"e2400393\"},\"PeriodicalIF\":3.2000,\"publicationDate\":\"2024-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"JCO Global Oncology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1200/GO-24-00393\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/11/21 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"JCO Global Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1200/GO-24-00393","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/11/21 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

目的:更好地了解西班牙早发结直肠癌(SECOC)子集中根据原籍国不同而存在的移民差异:我们从SECOC联盟中挑选了250名连续参与者。我们收集了患者和肿瘤的基线特征、结直肠癌(CRC)家族史和随访数据。还评估了是否存在错配修复缺陷。有关原籍国的特殊数据、在西班牙停留的时间(如果是在其他不同国家),以及规定获得西班牙国籍的 10 年分界线定义了比较感兴趣的变量:75%的早发性 CRC(EOCRC)患者(188 人)出生在西班牙,而另外 25% 的患者出生在西班牙以外的国家。从在西班牙生活到确诊为 EOCRC 的平均时间为 16.5 年。相比之下,大多数分析特征在不同组群之间显示出相同的比例。与非西班牙籍患者相比,只有西班牙籍患者的一级癌症家族遗传率较高(32.3%;P = .01),而非西班牙籍患者则以散发性为主(56.4%;P < .001)。在移民中,确诊 CRC 前在西班牙生活≤10 年的患者在确诊时更年轻(39.1 对 42.5),更多是男性(77.8 对 47.7),处于更晚期(88.8% 确诊为 III 期和 IV 期 [P=0.01]),复发率预后更差(29.4% 对 6.3%):尽管西班牙籍和非西班牙籍 EOCRC 患者之间的差异不大,但最显著的差异与新近抵达西班牙的移民的情况有关,因为他们的医疗保险较低,这可能与诊断延迟和随后的预后较差有关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Immigrant Health and Early-Onset Colorectal Cancer Disparities: Results From the Spanish Early-Onset Colorectal Cancer Consortium.

Purpose: To better understand immigration disparities among a Spanish Early-Onset Colorectal Cancer (SECOC) subset, according to the country of origin.

Patients and methods: We selected 250 consecutive participants from the SECOC consortium. Data on baseline patient and tumor characteristics, family history of colorectal cancer (CRC), and follow-up were collected. The presence of mismatch repair deficiency was also assessed. Special data regarding country of origin, time of stay in Spain in case of other different country, and a 10-year cutoff that specifies the obtaining of Spanish nationality defined the variables of interest for comparison.

Results: Seventy-five percent of patients with early-onset CRC (EOCRC) (188) were born in Spain, whereas the other 25% were born outside of Spain. The mean time of living in Spain until the EOCRC diagnosis was 16.5 years. Comparatively, most of the analyzed features showed equivalent proportions between cohorts. Only Spanish patients appeared to have more familial cancer component in first degree in general (32.3%; P = .01), compared with non-Spaniards, which showed a predominant sporadic component (56.4%; P < .001). Among immigrants, those patients living in Spain before CRC diagnosis ≤10 years were younger at diagnosis (39.1 v 42.5), more frequently male (77.8 v 47.7), were in more advanced stages (88.8% diagnosed at stage III and IV [P = .01]), and had a worse prognosis regarding recurrence rates (29.4% v 6.3%).

Conclusion: Although there were few differences between Spanish and non-Spanish EOCRC, the most remarkable difference was that linked with the situation of those immigrants who have recently arrived in Spain, in relation to their lower health coverage, which could be associated with the delay in the diagnosis and their subsequent worse prognosis.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
JCO Global Oncology
JCO Global Oncology Medicine-Oncology
CiteScore
6.70
自引率
6.70%
发文量
310
审稿时长
7 weeks
期刊最新文献
Beliefs on Causes of Cancer in the General Population, and the Association With Risk Perception and Lifestyle in a Multiethnic Setting. Efficacy and Safety of Biosimilar Cetuximab Versus Innovator Cetuximab in Indian Patients With Head and Neck Cancer: A Multicenter, Randomized, Double-Blind, Phase III Trial. Evaluation of the Stronger Together Peer Mentoring Model Among Patients With Breast and Gynecologic Cancer in Viet Nam. Germline Genetic Susceptibility Testing Among Emirati Nationals at Risk for Hereditary Breast and Ovarian Cancer Syndrome. Health-Related Quality of Life and Financial Burden in Ethiopian Patients With Chronic Myeloid Leukemia Receiving Tyrosine Kinase Inhibitors: A Cross-Sectional Study.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1